期刊文献+

乳腺癌血液学检测研究进展 被引量:1

Development of hematological test in breast cancer
原文传递
导出
摘要 早期无创伤性的乳腺癌血液学检测一直是研究热点。酶类、细胞因子类、糖蛋白类抗原、癌胚抗原、催乳素和血中癌基因蛋白等近年来研究较多,其中CA15-3和癌胚抗原具有重要的临床价值。寻找敏感性和特异性较高的血液学乳腺癌检测指标是极其重要的。 Early and non-invasive hematological test in breast cancer is always hot topic. In recent year, enzyme, cytokine, glycoprotein, carcinoembrynoic antigen (CEA), prolactin and oncogene protein are studied more, among them CA15-3 and CEA have important clinical value. Looking for hematological test markers which have high sensitivity and speciality is important work.
出处 《国际肿瘤学杂志》 CAS 2008年第9期684-686,共3页 Journal of International Oncology
关键词 乳腺肿瘤 血液学试验 Breast neoplasms Hematologic tests
  • 相关文献

参考文献25

  • 1Somiari SB, Somiari RI, Heckman CM, et al. Circulating MMP2 and MMP9 in breast cancer-potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer, 2006, 119(6) :1403-1411.
  • 2Sliwowska I, Kopczynski Z. Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B ( pro-MMP-9, 92 kDa) in serum of patients with breast cancer. Wiad Lek, 2007, 60(5-6) :241-247.
  • 3Svobodova S, Topolcan O, Holubec L, et al. Prognostic importance of thymidine kinase in colorectal and breast cancer. Anticancer Res, 2007, 27 (4A) : 1907-1909.
  • 4He Q, Fornander T, Johansson H, et al. Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer. Anticancer Res, 2006, 26(6C) :4753-4759.
  • 5Lyon DE, McCain NL, Walter J, et al. Cytokine comparisons between women with breast cancer and women with a negative breast biopsy. Nurs Res, 2008, 57( 1 ) :51-58.
  • 6Coskun U, Gtinel N, Toruner FB, et al. Serum leptin, protactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer. Neoplasma, 2003, 50( 1 ) :41-46.
  • 7Asgeirsson KS, Agrawal A, Allen C, et al. Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients. Breast Cancer Res, 2007, 9(6) :R75.
  • 8Coskun U, Gunel N, Sancak B, et al. Significance of serum vascular endothelial growth factor, insulin-like growth factor-Ⅰ levels and nitric oxide activity in breast cancer patients. Breast, 2003, 12 (2) :104-110.
  • 9Chong YM, Subramanian A, Sharma AK, et al. The potential clinical applications of insulin-like growth factor-1 ligand in human breast cancer. Anticancer Res, 2007, 27 ( 3 B) : 1617-1624.
  • 10Al-azawi D, Kelly G, Myers E, et al. CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer. BMC Cancer, 2006, 6:220.

同被引文献18

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部